Literature DB >> 32045616

Predictors of overall and test-specific colorectal Cancer screening adherence.

Constantine Daskalakis1, Melissa DiCarlo2, Sarah Hegarty3, Anuragh Gudur4, Sally W Vernon5, Ronald E Myers2.   

Abstract

This study investigated predictors of overall and test-specific colorectal cancer screening (CRCS). Stool blood test (SBT) and/or colonoscopy screening were offered to primary care patients in two randomized controlled trials which assessed the impact of behavioral interventions on screening. Data were obtained through surveys and electronic medical records. Among 1942 participants, 646 (33%) screened. Exposure to interventions was associated with higher overall CRCS by twofold to threefold; older age, African American race, being married, and having a higher screening decision stage were also associated with higher overall CRCS (odds ratios = 1.30, 1.31, 1.34, and 5.59, respectively). Intervention, older age, female gender, and being married were associated with higher SBT adherence, while preference for colonoscopy was associated with lower SBT adherence. Intervention and higher decision stage were associated with higher colonoscopy adherence, while preference for SBT was associated with lower colonoscopy adherence. Among older individuals, African Americans had higher overall CRCS than whites, but this was not true among younger individuals (interaction p = .041). The higher screening adherence of African Americans over whites was due to stronger screening with a non-preferred test, i.e., higher SBT adherence only among individuals who preferred colonoscopy and higher colonoscopy adherence only among individuals who preferred SBT. Intervention exposure, sociodemographic background, and screening decision stage predicted overall CRCS adherence. Gender and test preference also affected test-specific screening adherence. Interactions involving race and test preference suggest that it is important to provide both colonoscopy and SBT screening options to patients, particularly African Americans.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32045616      PMCID: PMC7415480          DOI: 10.1016/j.ypmed.2020.106022

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  30 in total

1.  Cancer screening - United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-01-27       Impact factor: 17.586

2.  Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians.

Authors:  Jasmin A Tiro; Sally W Vernon; Terry Hyslop; Ronald E Myers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

3.  A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey.

Authors:  David A Etzioni; Ninez A Ponce; Susan H Babey; Benjamin A Spencer; E Richard Brown; Clifford Y Ko; Neetu Chawla; Nancy Breen; Carrie N Klabunde
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

4.  Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.

Authors:  John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward
Journal:  Arch Intern Med       Date:  2012-04-09

5.  Development and validation of an instrument to measure factors related to colorectal cancer screening adherence.

Authors:  S W Vernon; R E Myers; B C Tilley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-10       Impact factor: 4.254

6.  Patterns and predictors of colorectal cancer test use in the adult U.S. population.

Authors:  Laura C Seeff; Marion R Nadel; Carrie N Klabunde; Trevor Thompson; Jean A Shapiro; Sally W Vernon; Ralph J Coates
Journal:  Cancer       Date:  2004-05-15       Impact factor: 6.860

7.  Fatalism among elderly African Americans. Effects on colorectal cancer screening.

Authors:  B D Powe
Journal:  Cancer Nurs       Date:  1995-10       Impact factor: 2.592

8.  A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening.

Authors:  Ronald E Myers; Heather Bittner-Fagan; Constantine Daskalakis; Randa Sifri; Sally W Vernon; James Cocroft; Melissa Dicarlo; Nora Katurakes; Jocelyn Andrel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-01       Impact factor: 4.254

9.  Race/Ethnicity, gender, weight status, and colorectal cancer screening.

Authors:  Heather Bittner Fagan; Ronald E Myers; Constantine Daskalakis; Randa Sifri; Arch G Mainous; Richard Wender
Journal:  J Obes       Date:  2011-12-10

10.  Colorectal cancer screening in African Americans: practice patterns in the United States. Are we doing enough?

Authors:  Abhijeet Waghray; Alok Jain; Nisheet Waghray
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-04-11
View more
  6 in total

1.  Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.

Authors:  Hua Bao; Zheng Wang; Xiaoji Ma; Wei Guo; Xiangyu Zhang; Wanxiangfu Tang; Xin Chen; Xinyu Wang; Yikuan Chen; Shaobo Mo; Naixin Liang; Qianli Ma; Shuyu Wu; Xiuxiu Xu; Shuang Chang; Yulin Wei; Xian Zhang; Hairong Bao; Rui Liu; Shanshan Yang; Ya Jiang; Xue Wu; Yaqi Li; Long Zhang; Fengwei Tan; Qi Xue; Fangqi Liu; Sanjun Cai; Shugeng Gao; Junjie Peng; Jian Zhou; Yang Shao
Journal:  Mol Cancer       Date:  2022-06-11       Impact factor: 41.444

2.  Persistent Barriers to Colorectal Cancer Screening Completion Amid Centralized Outreach: A Mixed Methods Study.

Authors:  Jocelyn V Wainwright; Shivan J Mehta; Alicia Clifton; Claire Bocage; Shannon N Ogden; Sarah Cohen; Katharine A Rendle
Journal:  Am J Health Promot       Date:  2021-12-31

3.  Predictors of Colorectal Cancer Screening Among African American Men Living with HIV.

Authors:  Terri-Ann Kelly; Soojong Kim; Loretta S Jemmott; John B Jemmott
Journal:  J Community Health       Date:  2021-05-08

4.  Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort.

Authors:  Lesley-Ann Miller-Wilson; Lila J Finney Rutten; Jack Van Thomme; A Burak Ozbay; Paul J Limburg
Journal:  Int J Colorectal Dis       Date:  2021-05-21       Impact factor: 2.571

5.  Colorectal Cancer Screening Prevalence and Adherence for the Cancer Prevention Project of Philadelphia (CAP3) Participants Who Self-Identify as Black.

Authors:  Elizabeth L Blackman; Camille Ragin; Resa M Jones
Journal:  Front Oncol       Date:  2021-07-30       Impact factor: 6.244

6.  Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.

Authors:  Ji-Bin Li; Zhi-Yu Qiu; Yu-Xiang Deng; Yin Li; Zhuo-Chen Lin; Yan-Ping Wu; Fan Weng; Huan Tian; Qing-Jian Ou; Cheng-Hua Gong; Zhi-Zhong Pan; De-Sen Wan; Jian-Hong Peng; Yu-Jing Fang
Journal:  Discov Oncol       Date:  2022-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.